Leukemia: all 5,475 studies
Page 38 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for ThrombocytopeniaCompletedNCT01488565Phase 2
- Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)Status unknownNCT01488344Phase 1/2
- Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell TransplantsTerminatedNCT01488253Phase 2
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01488162
- NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)CompletedNCT01486797Phase 2
- HLA-mismatched Microtransplantation for High Risk Acute Myeloid LeukemiaStatus unknownNCT01484171Phase 3
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedNCT01484015Phase 1
- Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell TransplantationWithdrawnNCT01483274Phase 1
- Providing Access to Cord Blood Units for TransplantsWithdrawnNCT01479582Phase 2
- ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid LeukemiaWithdrawnNCT01478074Phase 1
- Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With NilotinibCompletedNCT01475110
- CD19 CAR T Cells for B Cell Malignancies After Allogeneic TransplantCompletedNCT01475058Phase 1/2
- Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With ChemotherapyCompletedNCT01472107
- Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell TransplantationStatus unknownNCT01472055Phase 2
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
- Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007CompletedNCT01470924
- A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)CompletedNCT01468467Phase 1
- Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in JapanStatus unknownNCT01464411
- Korean Post-marketing Surveillance for Sprycel®CompletedNCT01464047
- A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT01463852Early Phase 1
- Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfilerTerminatedNCT01463410
- Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic SyndromeCompletedNCT01463046Phase 1
- Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)CompletedNCT01462578Phase 2
- A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except LeukemiaCompletedNCT01462175Phase 1
- Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid LeukaemiaCompletedNCT01460693Phase 3
- Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)CompletedNCT01460498Phase 1
- Lipoprotein Lipase Expression in Chronic Lymphocytic LeukemiaCompletedNCT01460238
- Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)CompletedNCT01459211Phase 2
- Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic LeukemiaCompletedNCT01457040Phase 2/3
- Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior TherapyCompletedNCT01456676Phase 1
- Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic LeukemiaWithdrawnNCT01456182Phase 1
- New Therapy for Advanced Stage Leukemia After Stem Cell TransplantationCompletedNCT01455272Not applicable
- Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell TransplantationCompletedNCT01455051Phase 2
- Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid LeukemiaTerminatedNCT01455025Phase 1
- Phase IV Observational Study in Chronic Lymphocytic LeukemiaCompletedNCT01453062
- Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01452646Phase 2
- Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)Status unknownNCT01451268Phase 1/2
- R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic LymphomaTerminatedNCT01446900Phase 2
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)Active, not recruitingNCT01446133Phase 2
- An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction ChemotherapyCompletedNCT01446081Phase 2
- Endothelial Function, Arterial Stiffness and ComponentsCompletedNCT01439217
- Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid LeukemiaCompletedNCT01438138
- Pharmacogenomics Validation for Imatinib in Chronic Myeloid LeukemiaCompletedNCT01437202
- Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)Status unknownNCT01435720Phase 1/2
- Treatment of Relapsed or Refractory Acute Myeloblastic LeukemiaCompletedNCT01435343Phase 1/2
- S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01434329
- Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeCompletedNCT01433965Phase 1
- AT9283 in Treating Young Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT01431664Phase 1
- Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic LeukemiaStatus unknownNCT01429610Phase 2
- Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateTerminatedNCT01426334Phase 1
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)CompletedNCT01423032Phase 2/3
- Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)CompletedNCT01422603Phase 1/2
- Vorinostat in ChildrenCompletedNCT01422499Phase 1/2
- Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid LeukemiaCompletedNCT01421875
- Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care TreatmentStatus unknownNCT01421862
- Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)CompletedNCT01419691Phase 2
- Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01419496
- Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)CompletedNCT01418430Phase 4
- Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and RituximabCompletedNCT01416974Phase 1
- Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesCompletedNCT01413568Phase 1/2
- A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of LeukemiaWithdrawnNCT01411904Not applicable
- Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT01410513Phase 1
- Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaTerminatedNCT01408160Phase 1
- Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531CompletedNCT01407757
- Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)CompletedNCT01404520Not applicable
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT01403415Phase 1
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLLCompletedNCT01400685Phase 1
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological MalignanciesCompletedNCT01399840Phase 1
- Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia PatientsCompletedNCT01398462Phase 1
- Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)CompletedNCT01397799Phase 1
- Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)TerminatedNCT01397734Phase 1
- Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)TerminatedNCT01397149Phase 1/2
- Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced LeukemiasCompletedNCT01396499Phase 1
- Cell Samples From Patients With LeukemiaCompletedNCT01395628
- An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic LeukaemiaCompletedNCT01395615
- Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML)CompletedNCT01394666
- Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to FludarabineCompletedNCT01392079Phase 2
- A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)CompletedNCT01390337Phase 1
- Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell TransplantCompletedNCT01390311Phase 1
- NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT01386619Phase 1/2
- Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In ChildrenCompletedNCT01385891Phase 2/3
- MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid LeukemiaCompletedNCT01385787
- Biomarkers in Blood Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01385150
- Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative MalignanciesStatus unknownNCT01385072Phase 1/2
- Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)CompletedNCT01382147Phase 3
- Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid LeukemiaCompletedNCT01380756Phase 1
- Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic LeukemiaCompletedNCT01380587
- Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 YearsStatus unknownNCT01376427Not applicable
- Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid LeukemiaCompletedNCT01373515Phase 1/2
- Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaCompletedNCT01372540Phase 1
- Intensified Rituimab Prephase Before FCR in Untreated B-CLLCompletedNCT01370772Phase 2
- Treatment of Acute Leukemia Relapse After AllotransplantationStatus unknownNCT01369368Phase 1/2
- Lenalidomide in Patients With Chronic Myelomonocytic LeukemiaStatus unknownNCT01368757Phase 1/2
- Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 TrialCompletedNCT01368523Phase 4
- Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)Status unknownNCT01366898Phase 4
- Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families StudyCompletedNCT01365975
- Unrelated Donor Stem Cell TransplantationCompletedNCT01364363Not applicable
- Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedNCT01363817Phase 1